Quarterly report · Q3
4578.TEDINET S100S3PH
Period2023-01-01 → 2023-09-30
Filed2023-10-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.48T | 2023-01-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥531.5bn | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.27T | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥451.8bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥202.7bn | 2023-01-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥72.0bn | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥114.8bn | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥47.7bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥213.2bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥74.4bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥173.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥146.0bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥53.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥161.7bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥59.1bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥133.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥111.0bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥41.3bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥165.3bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥60.3bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥114.0bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.4bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥3.42T | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥3.10T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.19T | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥892.2bn | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥840.3bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.53T | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.26T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.33T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.48T | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.23T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.30T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥518.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥471.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥477.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥186.0bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥211.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥171.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥74.8bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥81.6bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥60.4bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥82.4bn | 2023-01-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.5bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥84.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥297.99 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥108.93 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥246.8 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥204.66 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥76.04 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥297.99 | 2023-01-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥108.93 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥246.78 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥204.64 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥76.02 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.6% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 72.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-09-30 | ¥131.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-07-01 → 2023-09-30 | ¥44.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-09-30 | ¥99.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-07-01 → 2023-09-30 | ¥33.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥32.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥11.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-09-30 | ¥9.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-07-01 → 2023-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-09-30 | −¥32.9bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥11.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-09-30 | −¥32.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥11.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-09-30 | −¥37.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥12.1bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥28.5bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥11.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥28.4bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥11.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥12m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥10.6bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥2.6bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥359.1bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥132.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥359.0bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥132.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥95m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥40m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥28.3bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥992.4bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥354.6bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥992.4bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥354.6bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥191.5bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥57.9bn |
| —segment total | revenue | 2023-01-01 → 2023-09-30 | ¥1.51T |
| —segment total | revenue | 2023-07-01 → 2023-09-30 | ¥543.3bn |
| —segment total | revenue external | 2023-01-01 → 2023-09-30 | ¥1.48T |
| —segment total | revenue external | 2023-07-01 → 2023-09-30 | ¥531.5bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥32.9bn |
| —segment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥11.7bn |
| —segment total | segment profit | 2023-01-01 → 2023-09-30 | ¥240.1bn |
| —segment total | segment profit | 2023-07-01 → 2023-09-30 | ¥84.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥126.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-07-01 → 2022-09-30 | ¥43.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥94.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-07-01 → 2022-09-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥31.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥11.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥9.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥32.0bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥11.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥32.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥11.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥34.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥12.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥27.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥10.3bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥27.0bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥10.3bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥12m |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥5.6bn |
| jpcrp040300-q3r_E21183-000Consumer Productsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥3.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥325.6bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥119.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥325.6bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥119.9bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥7m |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥49.8bn |
| jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥819.3bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥290.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥819.3bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥290.0bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥84.5bn |
| jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥32.3bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥1.30T |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥463.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥1.27T |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥451.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥32.0bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥11.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥149.7bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥59.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 855
| Item | Context | Value | Unit |
|---|---|---|---|
| Other financial assets nca IFRS | CurrentQuarterInstant | 198551000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 53383000000 | JPY |
| Deferred tax assets IFRS | CurrentQuarterInstant | 91769000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 12156000000 | JPY |
| Other non current assets nca IFRS | CurrentQuarterInstant | 13181000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 1910608000000 | JPY |
| Non current assets IFRS | CurrentQuarterInstant | 2064428000000 | JPY |
| Assets IFRS | Prior1YearInstant | 3102638000000 | JPY |
| Assets IFRS | CurrentQuarterInstant | 3417971000000 | JPY |
| Trade and other payables2 cl IFRS | Prior1YearInstant | 198356000000 | JPY |
| Trade and other payables2 cl IFRS | CurrentQuarterInstant | 185633000000 | JPY |
| Bonds and borrowings cl IFRS | Prior1YearInstant | 26440000000 | JPY |
| Bonds and borrowings cl IFRS | CurrentQuarterInstant | 40832000000 | JPY |
| Lease liabilities cl IFRS | Prior1YearInstant | 17717000000 | JPY |
| Lease liabilities cl IFRS | CurrentQuarterInstant | 18312000000 | JPY |
| Other financial liabilities cl IFRS | Prior1YearInstant | 3307000000 | JPY |
| Other financial liabilities cl IFRS | CurrentQuarterInstant | 22334000000 | JPY |
| Income taxes payable cl IFRS | Prior1YearInstant | 28340000000 | JPY |
| Income taxes payable cl IFRS | CurrentQuarterInstant | 41984000000 | JPY |
| Provisions cl IFRS | Prior1YearInstant | 763000000 | JPY |
| Provisions cl IFRS | CurrentQuarterInstant | 788000000 | JPY |
| Contract liabilities cl IFRS | Prior1YearInstant | 13376000000 | JPY |
| Contract liabilities cl IFRS | CurrentQuarterInstant | 15343000000 | JPY |
| Other current liabilities cl IFRS | Prior1YearInstant | 250891000000 | JPY |
| Other current liabilities cl IFRS | CurrentQuarterInstant | 306310000000 | JPY |
| Total current liabilities IFRS | Prior1YearInstant | 539193000000 | JPY |
| Total current liabilities IFRS | CurrentQuarterInstant | 631539000000 | JPY |
| Bonds and borrowings ncl IFRS | Prior1YearInstant | 93775000000 | JPY |
| Bonds and borrowings ncl IFRS | CurrentQuarterInstant | 70343000000 | JPY |
| Lease liabilities ncl IFRS | Prior1YearInstant | 56229000000 | JPY |
| Lease liabilities ncl IFRS | CurrentQuarterInstant | 55413000000 | JPY |
| Other financial liabilities ncl IFRS | Prior1YearInstant | 30515000000 | JPY |
| Other financial liabilities ncl IFRS | CurrentQuarterInstant | 16162000000 | JPY |
| Retirement benefit liability ncl IFRS | Prior1YearInstant | 16011000000 | JPY |
| Retirement benefit liability ncl IFRS | CurrentQuarterInstant | 16448000000 | JPY |
| Provisions ncl IFRS | Prior1YearInstant | 1507000000 | JPY |
| Provisions ncl IFRS | CurrentQuarterInstant | 2300000000 | JPY |
| Contract liabilities ncl IFRS | Prior1YearInstant | 50736000000 | JPY |
| Contract liabilities ncl IFRS | CurrentQuarterInstant | 46584000000 | JPY |
| Deferred tax liabilities IFRS | Prior1YearInstant | 29511000000 | JPY |
| Deferred tax liabilities IFRS | CurrentQuarterInstant | 28451000000 | JPY |
| Other non current liabilities ncl IFRS | Prior1YearInstant | 22787000000 | JPY |
| Other non current liabilities ncl IFRS | CurrentQuarterInstant | 24939000000 | JPY |
| Non current labilities IFRS | Prior1YearInstant | 301076000000 | JPY |
| Non current labilities IFRS | CurrentQuarterInstant | 260643000000 | JPY |
| Liabilities IFRS | Prior1YearInstant | 840269000000 | JPY |
| Liabilities IFRS | CurrentQuarterInstant | 892183000000 | JPY |
| Share capital IFRS | Prior1YearInstant | 81690000000 | JPY |
| Share capital IFRS | CurrentQuarterInstant | 81690000000 | JPY |
| Capital surplus IFRS | Prior1YearInstant | 506579000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |